Companies: 10,795·Total market cap: $144.5T
USANA Health Sciences, Inc.

USANA Health Sciences, Inc.

USNANYSEConsumer Defensive● Active
$18.70
+$0.67(+3.72%)
Market Cap$345258306
P/E Ratio
52W High$38.32
52W Low$16.6
Overview

USANA Health Sciences, Inc.(USNA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · USNA · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2026-012024-122023-122022-122021-12
Revenue
Revenue$0.93B$0.85B$0.92B$1.00B$1.19B
Cost of Revenue$0.20B$0.18B$0.19B$0.21B$0.23B
Gross Profit$0.72B$0.68B$0.73B$0.79B$0.96B
Gross Margin %(computed)78.29%79.43%79.44%79.24%80.54%
Operating Expenses
R&D Expenses$0.00B$0.01B$0.01B$0.01B$0.01B
G&A Expenses$0.34B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$0.67B$0.61B$0.64B$0.68B$0.79B
Operating Income$0.05B$0.07B$0.09B$0.11B$0.17B
Operating Margin %(computed)5.50%7.76%10.11%10.78%14.34%
Interest Income$0.00B$0.01B$0.01B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax$0.04B$0.08B$0.10B$0.11B$0.17B
Income Tax Expense$0.03B$0.03B$0.04B$0.04B$0.05B
Net Income$0.01B$0.04B$0.06B$0.07B$0.12B
Net Margin %(computed)1.16%4.92%6.93%6.94%9.82%
Per Share & EBITDA
EPS (Basic)$0.58$2.20$3.33$3.60$5.78
Wtd Avg Shares0.02B0.02B0.02B0.02B0.02B
EBITDA$0.08B$0.10B$0.12B$0.13B$0.19B
EBITDA Margin %(computed)8.87%11.57%13.37%13.04%16.26%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解USANA Health Sciences, Inc.

关于USANA Health Sciences, Inc.(USNA)损益表

USANA Health Sciences, Inc.(USNA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2026财年,USNA实现营收$0.93B,毛利润$0.72B(毛利率78.29%),净利润$0.01B(净利率1.16%)。

常见问题

USNA · 4 问

USANA Health Sciences, Inc.(USNA)2026财年营收为$0.93B,同比up8.3%。

USNA revenueUSNA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08